We are live on
!
Find out more
AC
Adelphi Capital Portfolio holdings
AUM
$3.21M
1-Year Est. Return
121.6%
This Fund
S&P 500
This Quarter
Est. Return
+1.28%
1 Year Est. Return
+121.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$393M
AUM Growth
-$122M
(-24%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-32.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ryanair
RYAAY
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Takeda Pharmaceutical
TAK
|
+$138M |
| 2 |
Fidelity National Information Services
FIS
|
+$1.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 63.64% |
| 2 | Industrials | 36.36% |
| 3 | Healthcare | 0% |
Similar funds
TA
TAM
TMC
AV
MVPI
RIA
IAC
ALBM
Adelphi Capital's Q1 2021 Portfolio in Review
As of Q1 2021, Adelphi Capital held 3 positions worth $393M, down 24% from $515M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Adelphi Capital withdrew a net $127M in Q1 2021, closing 1 position and reducing 1 holding. Its most notable exit was Takeda Pharmaceutical, an estimated $138M position sold in full.
By sector, the portfolio is most concentrated in Technology at 64% of assets, up from 49% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Adelphi Capital added an estimated $12.3M to Ryanair.
- Adelphi Capital added most to Ryanair in Q1 2021, an estimated $12.3M increase.
- Adelphi Capital's biggest Q1 2021 reduction was Fidelity National Information Services, cutting an estimated $1.41M.
- Adelphi Capital fully exited Takeda Pharmaceutical in Q1 2021, selling an estimated $138M.
- Adelphi Capital's ten largest holdings make up 100% of its $393M portfolio in Q1 2021.
- Adelphi Capital opened 0 new positions and closed 1 in Q1 2021.
- Adelphi Capital's portfolio value fell 24% quarter-over-quarter to $393M.
Based on Adelphi Capital's 13F filing for Q1 2021, filed 22 Apr 2021.